NCT06335355 2024-03-28A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC PatientsShanghai Shengdi Pharmaceutical Co., LtdPhase 2/3 Not yet recruiting401 enrolled